Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

2.

Hypereosinophilic Syndrome With Eosinophilic Gastritis.

Nayak VH, Engin NY, Burns JJ, Ameta P.

Glob Pediatr Health. 2017 Apr 24;4:2333794X17705239. doi: 10.1177/2333794X17705239. eCollection 2017. No abstract available.

3.

Potential Adverse Consequences of Early Discharge for Newborns Who Meet American Academy of Pediatrics Criteria.

Gorman S, Lee A, Amin R, Burns JJ.

Clin Pediatr (Phila). 2018 Mar;57(3):352-354. doi: 10.1177/0009922817698807. Epub 2017 Mar 30. No abstract available.

PMID:
28357921
4.

Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.

Bouso JM, Burns JJ, Amin R, Livingston FR, Elidemir O.

Pediatr Pulmonol. 2017 Mar;52(3):324-330. doi: 10.1002/ppul.23646. Epub 2017 Jan 30.

PMID:
28135043
5.

Clusters of adolescent and young adult thyroid cancer in Florida counties.

Amin R, Burns JJ.

Biomed Res Int. 2014;2014:832573. doi: 10.1155/2014/832573. Epub 2014 Apr 28.

6.

The relationship between local food sources and open space to body mass index in urban children.

Burns JJ, Goff S, Karamian G, Walsh C, Hobby L, Garb J.

Public Health Rep. 2011 Nov-Dec;126(6):890-900. No abstract available.

7.
8.

Clinical practice guideline: tonsillectomy in children.

Baugh RF, Archer SM, Mitchell RB, Rosenfeld RM, Amin R, Burns JJ, Darrow DH, Giordano T, Litman RS, Li KK, Mannix ME, Schwartz RH, Setzen G, Wald ER, Wall E, Sandberg G, Patel MM; American Academy of Otolaryngology-Head and Neck Surgery Foundation.

Otolaryngol Head Neck Surg. 2011 Jan;144(1 Suppl):S1-30. doi: 10.1177/0194599810389949.

PMID:
21493257
9.

The influence of traditional herbal formulas on cytokine activity.

Burns JJ, Zhao L, Taylor EW, Spelman K.

Toxicology. 2010 Nov 28;278(1):140-59. doi: 10.1016/j.tox.2009.09.020. Epub 2009 Oct 7. Review.

PMID:
19818374
10.

Limitations of an optimum sustainable population or potential biological removal approach for conserving marine mammals: Pacific walrus case study.

Robards MD, Burns JJ, Meek CL, Watson A.

J Environ Manage. 2009 Oct;91(1):57-66. doi: 10.1016/j.jenvman.2009.08.016. Epub 2009 Sep 23. Review.

PMID:
19783356
11.

Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators.

Spelman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M.

Altern Med Rev. 2006 Jun;11(2):128-50. Review.

12.

The adolescent with a chronic illness.

Burns JJ, Sadof M, Kamat D.

Pediatr Ann. 2006 Mar;35(3):206-10, 214-6. Review.

PMID:
16570487
13.

Index of suspicion.

Cheng A, Russell J, Henriquez WN, Stroger JH Jr, Burns JJ.

Pediatr Rev. 2005 Oct;26(10):377-82. No abstract available.

PMID:
16199592
14.

Influence of prior sexual risk experience on response to intervention targeting multiple risk behaviors among adolescents.

Wu Y, Burns JJ, Stanton BF, Li X, Harris CV, Galbraith J, Wei L.

J Adolesc Health. 2005 Jan;36(1):56-63.

PMID:
15661597
15.

Depressive symptoms and health risk among rural adolescents.

Burns JJ, Cottrell L, Perkins K, Pack R, Stanton B, Hobbs G, Hobby L, Eddy D, Hauschka A.

Pediatrics. 2004 May;113(5):1313-20.

PMID:
15121947
16.

Validation of the Perkins Adolescent Risk Screen (PARS).

Adams CD, Perkins KC, Lumley V, Hughes C, Burns JJ, Omar HA.

J Adolesc Health. 2003 Dec;33(6):462-70.

PMID:
14642708
17.

Eating disorders in adolescents.

Burns JJ, Stanton B, Perkins K, Pack R, Hobby-Burns L.

W V Med J. 2003 Mar-Apr;99(2):60-6.

PMID:
12874915
18.

Models of case management in long term home health care.

Burns JJ.

J Long Term Home Health Care. 1995 Spring;14(2):12. No abstract available.

PMID:
10142949
19.

Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.

Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.

Drugs Exp Clin Res. 1992;18(8):311-7.

PMID:
1338041
20.

In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.

Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.

Chemotherapy. 1992;38(2):99-106.

PMID:
1317282
21.

The survival of the community health nurse in a Medicare environment.

Burns JJ, Fox A, Shelby IL, West D.

Caring. 1987 Apr;6(4):80-3. No abstract available.

PMID:
10301675
22.

Prevalence of angiographically recognizable atherosclerosis in non-dominant right coronary arteries.

Moreyra AE, Sclar C, Burns JJ, Kostis JB.

Angiology. 1984 Dec;35(12):760-6.

PMID:
6507942
23.

Recurrent coronary artery fistula.

Kostis JB, Burns JJ, Moreyra AE, Pichard AD.

Clin Cardiol. 1984 May;7(5):307-13.

24.

Cage size and exercise affects infarct size in rat after coronary artery cauterization.

Moskowitz RM, Burns JJ, DiCarlo EF, Flaim SF, Harrison TS, Peuler J, Zelis R.

J Appl Physiol Respir Environ Exerc Physiol. 1979 Aug;47(2):393-6.

PMID:
468697
25.

In honour of Bernard B. Brodie.

Burns JJ.

Pharmacology. 1979;19(5):221-2. No abstract available.

26.

The effect of ascorbic acid deficiency on extrahepatic microsomal metabolism of drugs and carcinogens in the guinea pig.

Kuenzig W, Tkaczevski V, Kamm JJ, Conney AH, Burns JJ.

J Pharmacol Exp Ther. 1977 Jun;201(3):527-33. No abstract available.

PMID:
864591
27.

Panel on public service drugs and new uses for old drugs.

Atkinson AJ Jr, Finkel MJ, Burns JJ, Hitchings GH, Kemp BA, de Dennis SR.

Clin Pharmacol Ther. 1975 Nov;18(5 Pt 2):659-62. No abstract available.

PMID:
1102245
28.

Metabolism of ascorbic acid. Introduction: overview of ascorbic acid metabolism.

Burns JJ.

Ann N Y Acad Sci. 1975 Sep 30;258:5-6. No abstract available.

PMID:
1060418
29.

Effect of ascorbic acid on amine-nitrite toxicity.

Kamm JJ, Dashman T, Conney AH, Burns JJ.

Ann N Y Acad Sci. 1975 Sep 30;258:169-74. No abstract available.

PMID:
1060400
30.

Perinatal drug metabolism and morphological changes in the hepatocytes of normal and phenobarbital-treated guinea pigs.

Kuenzig W, Kamm JJ, Boublik M, Jenkins F, Burns JJ.

J Pharmacol Exp Ther. 1974 Oct;191(1):32-44. No abstract available.

PMID:
4153895
31.

Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer.

Hansen HJ, Snyder JJ, Miller E, Vandevoorde JP, Miller ON, Hines LR, Burns JJ.

Hum Pathol. 1974 Mar;5(2):139-47. No abstract available.

PMID:
4811605
32.

L-DOPA: chemical modifications and biological evaluation.

Brossi A, Pool W, Sheppard H, Burns JJ, Kaiser A, Bigler R, Bartholini G, Pletscher A.

Adv Neurol. 1974;5:291-3. No abstract available.

PMID:
4474795
33.

Certain aspects of drug binding to nonplasma proteins as illustrated by studies with cyclizine, chlorcyclizine, and polymyxin B.

Kuntzman R, Jacobson M, Tsai I, Burns JJ, Burchall J, Koch A.

Ann N Y Acad Sci. 1973 Nov 26;226:131-47. No abstract available.

PMID:
4148961
34.

Protective effect of ascorbic acid on hepatotoxicity caused by sodium nitrite plus aminopyrine.

Kamm JJ, Dashman T, Conney AH, Burns JJ.

Proc Natl Acad Sci U S A. 1973 Mar;70(3):747-9.

35.

Metabolic interactions among environmental chemicals and drugs.

Conney AH, Burns JJ.

Science. 1972 Nov 10;178(4061):576-86.

PMID:
5086390
36.

EEG of children with various learning problems. I. Outpatient study.

Gerson IM, Barnes TC, Mannino A, Fanning JM, Burns JJ.

Dis Nerv Syst. 1972 Mar;33(3):170-7. No abstract available.

PMID:
5022452
37.

An experimental model in dogs for studying interactions of drugs with bishydroxycoumarin.

Welch RM, Harrison YE, Conney AH, Burns JJ.

Clin Pharmacol Ther. 1969 Nov-Dec;10(6):817-25. No abstract available.

PMID:
4186901
38.

Interaction of environmental agents and drugs.

Burns JJ.

Environ Res. 1969 Oct;2(5):352-9. No abstract available.

PMID:
4985962
39.

Therapeutic implications of drug metabolism.

Burns JJ.

Pure Appl Chem. 1969;19(1):219-29. No abstract available.

PMID:
4983537
40.

Stimulatory effect of phenobarbital and insecticides on warfarin metabolism in the rat.

Ikeda M, Conney AH, Burns JJ.

J Pharmacol Exp Ther. 1968 Aug;162(2):338-43. No abstract available.

PMID:
5666986
41.

IV. Pharmacogenetics and drug toxicity. Variation of drug metabolism in animals and the prediction of drug action in man.

Burns JJ.

Ann N Y Acad Sci. 1968 Jul 31;151(2):959-67. No abstract available.

PMID:
4189972
42.

Importance of tissue and plasma binding in determining the retention of norchlorcyclizine and norcyclizine in man, dog and rat.

Kuntzman R, Tsai I, Burns JJ.

J Pharmacol Exp Ther. 1967 Nov;158(2):332-9. No abstract available.

PMID:
4383640
43.

Implications of enzyme induction in drug toxicity studies.

Welch RM, Harrison YE, Burns JJ.

Toxicol Appl Pharmacol. 1967 Mar;10(2):340-51. No abstract available.

PMID:
4962253
44.

Metabolic blockade by methoxamine and its analogs.

Burns JJ, Salvador RA, Lemberger L.

Ann N Y Acad Sci. 1967 Feb 10;139(3):833-40. No abstract available.

PMID:
5232346
45.

N-oxide formation: a new route for inactivation of the antihistaminic chlorcyclizine.

Kuntzman R, Phillips A, Tsai I, Klutch A, Burns JJ.

J Pharmacol Exp Ther. 1967 Feb;155(2):337-44. No abstract available.

PMID:
4381640
46.

Effects of pesticides on drug and steroid metabolism.

Conney AH, Welch RM, Kuntzman R, Burns JJ.

Clin Pharmacol Ther. 1967 Jan-Feb;8(1):2-10. No abstract available.

PMID:
6016284
47.

The metabolism of acetophenetidin and N-acetyl-p-aminophenol in the cat.

Welch RM, Conney AH, Burns JJ.

Biochem Pharmacol. 1966 May;15(5):521-31. No abstract available.

PMID:
5961431
48.

Enzyme induction and inhibition in studies on the pharmacological actions of acetophenetidin.

Conney AH, Sansur M, Soroko F, Koster R, Burns JJ.

J Pharmacol Exp Ther. 1966 Jan;151(1):133-8. No abstract available.

PMID:
5902170
49.

Metabolism of tyramine to dopamine by liver microsomes.

Lemberger L, Kuntzman R, Conney AH, Burns JJ.

J Pharmacol Exp Ther. 1965 Nov;150(2):292-7. No abstract available.

PMID:
5855884
50.

Enzyme stimulation and inhibition in the metabolism of drugs.

Burns JJ, Conney AH.

Proc R Soc Med. 1965 Nov;58(11 Part 2):955-60.

Supplemental Content

Loading ...
Support Center